CAS 132-17-2
:benztropine mesylate
Description:
Benztropine mesylate is a synthetic compound primarily used in the treatment of Parkinson's disease and drug-induced extrapyramidal symptoms. It acts as an anticholinergic agent, helping to restore the balance of neurotransmitters in the brain, particularly by inhibiting the action of acetylcholine. The substance is characterized by its white to off-white crystalline powder form, which is soluble in water and alcohol, making it suitable for various pharmaceutical formulations. Its chemical structure includes a benztropine moiety, which contributes to its pharmacological effects, and a mesylate group that enhances its solubility and stability. Benztropine mesylate is typically administered orally or via injection, and its dosage must be carefully managed to minimize side effects, which can include dry mouth, blurred vision, and constipation. As with many medications, it is essential to consider potential interactions with other drugs and underlying health conditions before use. Overall, benztropine mesylate plays a significant role in managing movement disorders associated with neurological conditions.
Formula:C21H25NO·CH4O3S
InChI:InChI=1/C21H25NO.CH4O3S/c1-22-18-12-13-19(22)15-20(14-18)23-21(16-8-4-2-5-9-16)17-10-6-3-7-11-17;1-5(2,3)4/h2-11,18-21H,12-15H2,1H3;1H3,(H,2,3,4)/t18-,19+,20+;
InChI key:InChIKey=CPFJLLXFNPCTDW-BWSPSPBFNA-N
SMILES:C(O[C@H]1C[C@@]2(N(C)[C@](C1)(CC2)[H])[H])(C3=CC=CC=C3)C4=CC=CC=C4.S(C)(=O)(=O)O
Synonyms:- (3-Endo)-3-(Diphenylmethoxy)-8-Methyl-8-Azabicyclo[3.2.1]Octane Methanesulfonate (1:1)
- 1α<span class="text-smallcaps">H</smallcap>,5α<smallcap>H</span>-Tropane, 3α-(diphenylmethoxy)-, methanesulfonate
- 3-(Diphenylmethoxy)-8-Methyl-8-Azabicyclo[3.2.1]Octane Methanesulfonate (1:1)
- 3-(Diphenylmethoxy)-8-Methyl-8-Azabicyclo[3.2.1]Octane Sulfate
- 3-Diphenylmethoxytropane mesylate
- 3-Diphenylmethoxytropane methanesulfonate
- 8-Azabicyclo[3.2.1]octane, 3-(diphenylmethoxy)-8-methyl-, (3-endo)-, methanesulfonate
- 8-Azabicyclo[3.2.1]octane, 3-(diphenylmethoxy)-8-methyl-, (3-endo)-, methanesulfonate (1:1)
- 8-Azabicyclo[3.2.1]octane, 3-(diphenylmethoxy)-8-methyl-, endo-, methanesulfonate
- Benzatropine Mesilate
- Benzatropine methanesulfonate
- Benzotropine mesylate
- Benzotropine methanesulfonate
- Benztropine Methane Sulfonate
- Benztropine methanesulfonate
- Cobrentin methanesulfonate
- Cogentin
- Cogentin methanesulfonate
- Cogentinol
- Mk 02
- NSC 169913
- NSC 42199
- Tropine benzohydryl ether methanesulfonate
- 1αH,5αH-Tropane, 3α-(diphenylmethoxy)-, methanesulfonate
- benzotropinemethanesulfonate
- cobrentinmethanesulfonate
- benzatropinemethanesulfonate
- 3-(DIPHENYLMETHOXY)-8-METHYL-8-AZABICYCLO[3.2.1]OCTANE METHANE SULFONATE
- 3-diphenylmethoxytropanemesylate
- 5-alpha-h-tropane,3-alpha-(diphenylmethoxy)-1-alpha-methanesulfonate
- 3-(diphenylmethoxy)-8-azabicyclo(3.2.1)octanendo-8-azabicyclo(3.2.1)octanmethanesulfonate
- 3-diphenylmethoxytropanemethanesulfonate
- endo-3-(diphenylmethoxy)-8-methyl-8-azoniabicyclo[3.2.1]octane methanesulphonate
- cogentinmethanesulfonate
- benztropinemesilate
- cogentinmesylate
- mk02
- 3-alpha-(diphenylmethoxy)-1-alpha-h,5-alpha-h-tropanemethanesulfonate
- BENZTROPINE MESYLATE
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 14 products.
Benzotropine methanesulfonate
CAS:<p>Muscarinic receptor antagonist</p>Formula:C21H25NO·CH3SO3HColor and Shape:White to off-white, PowderMolecular weight:403.54Benzatropine mesilate
CAS:Benzatropine mesilateFormula:C21H25NOCH3SO3HPurity:95.3%Color and Shape:WhiteMolecular weight:403.18173Benztropine Mesylate
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFormula:C21H25NO·CH4O3SColor and Shape:White Crystalline PowderMolecular weight:403.18173(1R,3R,5S)-3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane; methanesulfonic acid
CAS:Formula:C22H29NO4SPurity:98%Color and Shape:SolidMolecular weight:403.5350Benztropine mesylate
CAS:<p>Benztropine mesylate (Benztropine methanesulfonate) is a centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON</p>Formula:C21H25NO·CH4SO3Purity:98.41% - 99.96%Color and Shape:White Crystalline Powder; Odourless Or Almost OdourlessMolecular weight:403.53Benztropine-13C-d3 Mesylate
CAS:Formula:C2013CH22D3NO·CH4O3SColor and Shape:White To Off-White SolidMolecular weight:311.45 96.10Benztropine Mesylate
CAS:Formula:C21H25NO·CH4O3SColor and Shape:White To Off-White SolidMolecular weight:307.44 96.11Benztropine Mesylate
CAS:Formula:C21H25NO·CH4O3SPurity:>98.0%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:403.54Benztropine Mesilate
CAS:Controlled ProductFormula:C21H25NO·CH4O3SColor and Shape:NeatMolecular weight:403.54Benzotropine Mesylate
CAS:Controlled Product<p>Applications Used as an antiparkinsonian.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Hai, N., et al.: Int. J. Pharm., 357, 55 (2008), Sanderson, H., et al.: Toxicol. Lett., 187, 84 (2009),<br></p>Formula:C21H25NO·CH4O3SColor and Shape:WhiteMolecular weight:403.54Benztropine mesylate
CAS:<p>Benztropine is a drug that binds to the 5-HT2 receptors in the brain, which are involved in the regulation of many physiological functions, including motor control and memory. Benztropine is used primarily as an antiparkinsonian drug. It also has been shown to inhibit uptake of dopamine by blocking the dopamine transporter. This inhibition prevents reuptake of dopamine into presynaptic neurons, leading to increases in extracellular levels of dopamine and increased activity at dopaminergic synapses. Benztropine has been found to be a low-potency inhibitor of binding to certain other drugs, such as tricyclic antidepressant drugs and pharmacological agents.</p>Formula:C21H25NO·CH4O3SPurity:Min. 95%Color and Shape:PowderMolecular weight:403.54 g/molendo-3-(Diphenylmethoxy)-8-methyl-8-Azabicyclo[3.2.1]octane methanesulfonate
CAS:Formula:C22H29NO4SPurity:98%Molecular weight:403.54













